A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/11/2007	US20070237760 Detection and treatment of cancer
10/11/2007	US20070237759 Antibodies that bind PAR-2
10/11/2007	US20070237758 Immunoglobulin fusion protein formulations
10/11/2007	US20070237752 Methods and Compositions for Enhancing Engraftment of Hematopoietic Stem Cells
10/11/2007	US20070237713 PCan065 Antibody Compositions and Methods of Use
10/11/2007	US20070237712 Methods of Redistributing Apical Target Antigens to Detect and Treat Cellular Proliferative Disease
10/11/2007	US20070237711 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin
10/11/2007	DE202007004567U1 Verwendung einer adjuvierten Allergievakzinformulierung zur parenteralen Verabreichung Using a adjuvanted Allergievakzinformulierung for parenteral administration
10/11/2007	CA2649321A1 Pharmaceutical composition containing the nmb0938 protein
10/11/2007	CA2648618A1 Novel anti-cd98 antibody
10/11/2007	CA2647846A1 Method for control of blood kinetics of antibody
10/11/2007	CA2647808A1 Antibodies against amyloid-beta peptide
10/11/2007	CA2647566A1 Vaccine against streptococci
10/11/2007	CA2647465A1 Pharmaceutical composition containing the nmb0606 protein
10/11/2007	CA2647455A1 Processes for the conjugation of poly n-acetylated glucosamine to a carrier protein
10/11/2007	CA2647450A1 Process for producing a staphylococcal conjugate
10/11/2007	CA2647441A1 Immunogenic composition
10/11/2007	CA2647282A1 Ctla4 antibody combination therapy
10/11/2007	CA2647060A1 Synthetic archaeal glycolipid adjuvants
10/11/2007	CA2646421A1 Live attenuated salmonella vaccine
10/11/2007	CA2645904A1 Pseudomonas aeruginosa outer membrane protein pa0427
10/11/2007	CA2643740A1 Live attenuated salmonella vaccine
10/11/2007	CA2643592A1 A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same
10/11/2007	CA2638821A1 Gene disruptons, compositions and methods relating thereto
10/11/2007	CA2635409A1 Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli
10/11/2007	CA2632218A1 Il-21 receptor antagonists
10/10/2007	EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007	EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007	EP1842551A1 E-selectin for treating or preventing stroke
10/10/2007	EP1842550A2 Composition for inducing immunotolerance
10/10/2007	EP1842549A2 Optimized minigenes and peptides encoded thereby
10/10/2007	EP1841860A2 Mycobacteria with mannose cap-deficient lipoarabinomannan
10/10/2007	EP1841795A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/10/2007	EP1841794A2 Adam-9 modulators
10/10/2007	EP1841793A2 Ovr110 antibody compositions and methods of use
10/10/2007	EP1841788A1 Novel snake toxin
10/10/2007	EP1841467A2 Combination cancer therapy with anti-psma antibodies
10/10/2007	EP1841457A2 Tergeted apheresis for the treatment of rheumaoid arthritis
10/10/2007	EP1841456A2 Stabilized liquid polypeptide formulations
10/10/2007	EP1841455A1 Humanized anti-amyloid antibody
10/10/2007	EP1841454A2 Treatment method
10/10/2007	EP1841453A2 Treatment of pre-eclampsia in pregnant women using targeted apheresis
10/10/2007	EP1841452A2 Single domain antibodies against tnfr1 and methods of use therefor
10/10/2007	EP1841451A2 Peptides for delivery of mucosal vaccines
10/10/2007	EP1841450A2 Method for producing a vaccine for the treatment of cancer
10/10/2007	EP1511859B1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
10/10/2007	EP1511509B1 Compositions and methods for treating diabetes
10/10/2007	EP1414994B1 Vaccinia virus for diagnosis and therapy of tumors
10/10/2007	EP1272215B1 Pharmaceutical preparations comprising modified peptides
10/10/2007	EP1261317B1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
10/10/2007	EP1225220B1 Elimination of gal alpha 1-3 gal from swine tissue with endo-beta-galactosidase c
10/10/2007	EP1183044B1 Adjuvant combinations for immunization and vaccines
10/10/2007	EP1177301B1 Chlamydia antigens and corresponding dna fragments and uses thereof
10/10/2007	EP1162950B1 Media in the form of complex dispersions, method for preparing same and uses
10/10/2007	EP1155322B1 Compounds and methods for diagnosing trypanosoma cruzi infection
10/10/2007	EP1090924B1 Tumor antigen peptides originating in cyclophilin b
10/10/2007	EP0666760B2 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
10/10/2007	CN101052718A Mutated amyloid protein
10/10/2007	CN101052655A CTLA-4 antibody and aromatase inhibitor combination of treatment for breast cancer
10/10/2007	CN101052654A Polypeptide variants with altered effector function
10/10/2007	CN101052653A Anti-Fc-gamma RIIB receptor antibody and uses therefor
10/10/2007	CN101052421A Phospholipase enzymes c-ªå regulating and its application for controlling pain and injury effect
10/10/2007	CN101052419A Antagonizing interleukin-21 receptor activity
10/10/2007	CN101052418A Functional composition or food comprising whey protein and antibody derived from milk or antibody
10/10/2007	CN101052417A Prevention and treatment of synucleinopathic and amyloidogenic disease
10/10/2007	CN101052416A Improved adjuvant theraphy of G250-expressing tumors
10/10/2007	CN101052415A Methods and compositions for treating and preventing inflammatory conditions
10/10/2007	CN101052414A Immunogenic HBc chimer particles having enhanced stability
10/10/2007	CN101052413A Use of specific histones for the treatment of parasitic diseases
10/10/2007	CN101052412A Amebiasis subunit vaccine
10/10/2007	CN101052411A VLP-antigen conjugates and their uses as vaccines
10/10/2007	CN101049508A Carrier bacterin of attenuated typhoid bacterium of carrying tubercle branch bacillus Ag85B
10/10/2007	CN101049502A Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/10/2007	CN100342030C Method of testing anticancer agent-sensitivity of tumor cells
10/10/2007	CN100342017C Gene recombined chemotaxis antigen vaccine
10/10/2007	CN100341896C Anti-GP39 antibodies and uses therefor
10/10/2007	CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/10/2007	CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
10/10/2007	CN100341571C Medicine for treating tumor and use thereof
10/10/2007	CN100341570C Preparation method of protein chip
10/10/2007	CA2564435A1 Methods for monitoring and treating intestinal disorders
10/09/2007	US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007	US7279560 Administering monoclonal antibodies to inhibit transmission of costimulatory signal of lymphocytes; antiallergens; autoimmune diseases
10/09/2007	US7279556 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response
10/09/2007	US7279555 Derived from duck hepatitis B virus core protein; haptens; gene therapy
10/09/2007	US7279464 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA)
10/09/2007	US7279459 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
10/09/2007	US7279322 Electrospraying apparatus and method for coating particles
10/09/2007	US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007	US7279306 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
10/09/2007	US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007	US7279295 Allergen
10/09/2007	US7279172 Treatment of autoimmune conditions with copolymer 1 and related copolymers
10/09/2007	US7279171 Containing an immunogenic amount of a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2; nucleic acid vectors for the expression of MOMP polypeptides and MOMP polypeptide fusion proteins; immunization
10/09/2007	US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis
10/09/2007	US7279169 A diphtheria toxoid, a tetanus toxoid, and a detoxified pertussis holotoxin; and a detoxified E. coli heat labile toxin that is is LT-K63 or LT-R72; is administered intranasally
10/09/2007	US7279168 Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
10/09/2007	US7279167 Nucleotide sequences coding viral protein for use in treatment and prevention of viral disease in fish; veterinary medicine
10/09/2007	US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
10/09/2007	US7279165 Amyloid β1-6 antigen arrays

1 ... 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 ... 1823